BioMarker Strategies: BioMarker Strategies Announces Chinese Patent for PathMAP Functional Signaling Profile Technology

Compositions and Methods for Prediction of Drug Sensitivity Resistance and Disease Progression Chinese Patent ZL 201180030332.9 Exclusivity until April 2031 BioMarker Strategies LLC today announced that the Chinese Patent ...